×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Volver a Agenda
Session 22: Interactions with FDA - Part 1
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- FDA’s guidance on meetings
- Time course of events in requesting and preparing for a meeting
- Objectives and conduct of specific meetings with FDA
¿Tiene una cuenta?